With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact through their public offerings. According to Benzinga Pro, these enticing companies are scheduled to trade publicly this week.
BrightSpring Health Services, Inc (BTSG) becomes publicly listed starting on Jan. 26, 2024. The company has a price range set between $15.00 and $18.00 with a 180-day lockup period. BrightSpring Health Services, Inc will be offering 53,333,000 shares at a per-share value of $16.50.
CG Oncology, Inc. (CGON) becomes publicly listed starting on Jan. 25, 2024. The company has a price range set between $16.00 and $18.00 with a 180-day lockup period. CG Oncology, Inc. will be offering 11,800,000 shares at a per-share value of $17.00.
HW Electro Co., Ltd (HWEP) will be trading publicly starting on Jan. 24, 2024. HW Electro Co., Ltd will be offering 3,750,000 shares at a per-share value of $4.00 with an insider lock-up period of 180 days.
An initial public offering, or IPO, is the transitional process of a private company deciding to go public and offer shares to investors on an exchange. Typically, IPOs offer companies the ability to build capital. Before a company becomes publicly listed, it must meet SEC requirements and work with investment banks through audits to determine pricing, offering date, and other important data points before the offering.
Companies and investment banks will work to establish a price range that the stock is expected to sell between. This is known as an offering range. Once a company goes public, its stock comes with an opening price. The insider lock-up period is usually a set number of days after an IPO where company insiders, or employees with a 10% or higher stake in their company, cannot sell shares.
It is important to note that investing in IPOs can be risky and requires careful consideration. Investors should thoroughly research the company, its financials, and market conditions before making any investment decisions. Seeking advice from a financial advisor is always recommended.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
